Chevy Chase Trust Holdings LLC Grows Holdings in The Clorox Company $CLX

Chevy Chase Trust Holdings LLC increased its position in The Clorox Company (NYSE:CLX) by 0.9% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 88,212 shares of the company’s stock after acquiring an additional 790 shares during the quarter. Chevy Chase Trust Holdings LLC owned about 0.07% of Clorox worth $10,592,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CLX. Wealth Enhancement Advisory Services LLC increased its holdings in Clorox by 17.9% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 57,934 shares of the company’s stock worth $8,531,000 after acquiring an additional 8,793 shares in the last quarter. Exchange Traded Concepts LLC boosted its stake in Clorox by 10.2% in the 1st quarter. Exchange Traded Concepts LLC now owns 3,612 shares of the company’s stock worth $532,000 after purchasing an additional 333 shares during the period. QRG Capital Management Inc. boosted its stake in Clorox by 10.0% in the 1st quarter. QRG Capital Management Inc. now owns 2,492 shares of the company’s stock worth $367,000 after purchasing an additional 226 shares during the period. State of Alaska Department of Revenue boosted its stake in Clorox by 2.2% in the 1st quarter. State of Alaska Department of Revenue now owns 14,430 shares of the company’s stock worth $2,124,000 after purchasing an additional 315 shares during the period. Finally, Envestnet Portfolio Solutions Inc. boosted its stake in Clorox by 12.3% in the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 28,916 shares of the company’s stock worth $4,258,000 after purchasing an additional 3,161 shares during the period. 78.53% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research firms have weighed in on CLX. BNP Paribas Exane dropped their price target on Clorox from $118.00 to $110.00 and set an “underperform” rating for the company in a research note on Friday. Barclays dropped their price target on Clorox from $118.00 to $112.00 and set an “underweight” rating for the company in a research note on Tuesday, September 30th. TD Cowen dropped their price target on Clorox from $120.00 to $117.00 and set a “hold” rating for the company in a research note on Wednesday, October 1st. Morgan Stanley dropped their price target on Clorox from $150.00 to $137.00 and set an “equal weight” rating for the company in a research note on Friday, August 1st. Finally, The Goldman Sachs Group lowered their target price on Clorox from $115.00 to $110.00 and set a “sell” rating for the company in a research report on Wednesday, October 1st. One investment analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and four have issued a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Reduce” and an average target price of $130.20.

Insiders Place Their Bets

In related news, COO Eric H. Reynolds sold 15,041 shares of the stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the sale, the chief operating officer directly owned 54,221 shares of the company’s stock, valued at $6,711,475.38. This represents a 21.72% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.63% of the stock is owned by company insiders.

Clorox Stock Up 1.8%

NYSE CLX opened at $119.73 on Monday. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The company has a market capitalization of $14.58 billion, a P/E ratio of 18.36, a P/E/G ratio of 0.99 and a beta of 0.52. The Clorox Company has a one year low of $116.53 and a one year high of $171.37. The stock has a 50 day moving average price of $121.61 and a 200-day moving average price of $127.58.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.24 by $0.63. The company had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.Clorox’s revenue was up 4.5% on a year-over-year basis. During the same period last year, the company earned $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, equities analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be issued a dividend of $1.24 per share. This represents a $4.96 annualized dividend and a yield of 4.1%. The ex-dividend date is Wednesday, October 22nd. Clorox’s dividend payout ratio is presently 76.07%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.